Skip to main content
. Author manuscript; available in PMC: 2018 Jun 12.
Published in final edited form as: RSC Adv. 2017 Jun 12;7(48):30177–30184. doi: 10.1039/C7RA05397E

Figure 3.

Figure 3

The viable cell reduction of B. subtilis cells and E. coli cells. (A) B. subtilis and (B) E. coli cells upon the treatments with EDA-CDots samples of ΦF 7.5%, 17%, and 27% at 15.8 µg/mL under lab light treatment for 1 h and 3 h.